2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
14
Multiple Myeloma
12
Pain, Postoperative
10
Neoplasms
9
Agnosia
8
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Cancer Pain
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Lymphoma
4
Leukemia
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Burkitt Lymphoma
4
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Lymphoma, B-Cell
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Hairy Cell
3
Hematologic Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Trigger Finger Disorder
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Philadelphia Chromosome
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Interventions
Anastrozole
5
Letrozole
4
Surveys and Questionnaires
3
Aromatase Inhibitors
3
exemestane
2
Testosterone
2
Fatty Acids, Omega-3
2
Exercise
2
Educational Status
2
Acupuncture Therapy
2
methyl hydroxyethyl cellulose
1
guizhi-shaoyao-zhimu decoction
1
canakinumab
1
Yoga
1
Walking
1
Vitamin B 12
1
Therapeutics
1
Tamoxifen
1
Occupational Therapy
1
Hyaluronic Acid
1
Glucosamine
1
Glucaric Acid
1
Gabapentin
1
Fish Oils
1
Docosahexaenoic Acids
1
Diphosphonates
1
Diet Therapy
1
Denosumab
1
Curcumin
1
Chondroitin Sulfates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Arthralgia
×
Acetaminophen
×
Clear all
NCT04408560
2022-09-19
ARHOMA2
Institut Jean-Godinot
Phase NA
Completed
140 enrolled